Free Trial

Pito Chickering Analyst Performance

Sr. sell-side analyst at Deutsche Bank Aktiengesellschaft

Pito Chickering is a stock analyst at Deutsche Bank Aktiengesellschaft, covering 11 publicly traded companies across a range of sectors. Over the past year, Pito Chickering has issued 3 stock ratings, including buy and hold recommendations. While full access to Pito Chickering's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Pito Chickering's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
17 Last 6 Years
Buy Recommendations
88.24% 15 Buy Ratings
Companies Covered
11 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy88.2%15 ratings
Hold11.8%2 ratings
Sell0.0%0 ratings

Out of 17 total stock ratings issued by Pito Chickering at Deutsche Bank Aktiengesellschaft, the majority (88.2%) have been Buy recommendations, followed by 11.8% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
72.7% of companies on NYSE
8 companies
NASDAQ
27.3% of companies on NASDAQ
3 companies

Pito Chickering, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 11 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
11 companies
100.0%

Pito Chickering of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - OUTP/HM CRE
3 companies
27.3%
MED PRODUCTS
3 companies
27.3%
MEDICAL SERVICES
2 companies
18.2%
MED - HOSPITALS
2 companies
18.2%
MED INSTRUMENTS
1 company
9.1%

Pito Chickering's Ratings History at Deutsche Bank Aktiengesellschaft

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
9/8/2025Set Price Target$26.17$30.00Buy
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
7/25/2025Boost Price Target$75.68$94.00Buy
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
7/23/2025Boost Price Target$175.35$178.00Hold